Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALBEMARLE CORPALB · Entity 2581 | Director | July 01, 2025 | July 03, 2025 |
| EASTMAN CHEMICAL COEMN · Entity 1780 | Director | October 07, 2026 | October 09, 2026 |
| WESCO INTERNATIONAL INCWCC · Entity 3330 | Director | February 16, 2017 | February 21, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALBEMARLE CORP
Report date July 01, 2025 · Filed July 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,085 |
Ending reported balance
After 2025-07-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-07-01 · Grant · Acquired 2,725 · Balance 8,048 F1: Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026. Row 2 · 2025-07-01 · Grant · Acquired 37 · Balance 8,085 F2: Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026.
F2: Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.
EASTMAN CHEMICAL CO
Report date October 07, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 19,159 |
Reported balance
After 2026-10-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-07 · Grant · Acquired 480 · Balance 19,159 F1: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F3: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.
F2: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash.
F3: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026.
WESCO INTERNATIONAL INC
Report date February 16, 2017 · Filed February 21, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,689 |
Reported balance
After 2017-02-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-02-16 · Grant · Acquired 1,689 · Balance 1,689 F1: Each Restricted Stock Unit represents a contingent right to receive one share of WESCO Common Stock. F2: The Restricted Stock Units vest in three years from the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one share of WESCO Common Stock.
F2: The Restricted Stock Units vest in three years from the date of the grant.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date April 20, 2023 · Filed April 20, 2023
Section 16 reporting ended · disclosed 2023-04-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 1,794 |
Reported balance
Holding disclosure · report date 2023-04-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,794 F4: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023. Award will be pro-rated based on completed months served in the current year. F3: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 28,925 |
Reported balance
Holding disclosure · report date 2023-04-20 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 28,925 F3: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1) and the total includes the vested portion that was subsequently deferred for years 2013 and later. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 737 |
Reported balance
Holding disclosure · report date 2023-04-20 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 737 F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). |
Filing footnotes · ownership attribution and instrument terms
F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1) and the total includes the vested portion that was subsequently deferred for years 2013 and later.
F2: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F3: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.
F4: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023. Award will be pro-rated based on completed months served in the current year.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2026 Filed Oct 9, 2026 20:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 480 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001023582-26-000003 · wk-form4_1791576137.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,159 Underlying: Common Stock · 480 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · shares: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F3 · balance_after: Includes units credited since April 8, 2026, as reinvestment of dividend equivalents for phantom shares deferred under the Directors' Deferred Compensation Plan ("DDCP"), including credits for accrued dividend equivalents that were made to the directors DDCP account on October 7, 2026. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:23 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GiftCommon Stock | 7,860 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000145 · wk-form4_1788467000.xml · nonDerivative · entry 3 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · O'Brien Family Dynasty Trust Disclosed balance after: 7,860 F1 · ownership.nature: Katherine B. O'Brien, TTEE Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:23 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GiftCommon Stock | 2,482 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000145 · wk-form4_1788467000.xml · nonDerivative · entry 2 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Revocable Trust Disclosed balance after: 0 Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:23 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GiftCommon Stock | 5,378 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000145 · wk-form4_1788467000.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,628 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:08 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000113 · wk-form4_1778530105.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,456 F1 · shares: Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:08 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 408 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000082 · wk-form4_1775851711.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,137 Underlying: Common Stock · 408 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · shares: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash. F3 · balance_after: Includes dividend equivalents reinvested in additional Phantom Stock Units. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 22:23 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 487 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001023582-25-000006 · wk-form4_1760048597.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,407 Underlying: Common Stock · 487 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F2 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F3 · balance_after: Includes 395 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| August 27, 2025 Filed Aug 28, 2025 20:14 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | PurchaseCommon Stock | 1,450 | $68.81 | $99,775.95 |
DisclosureSEC source: 0001023582-25-000004 · wk-form4_1756412046.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,828 Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 19:34 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 37 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000123 · wk-form4_1751571271.xml · nonDerivative · entry 2 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,085 F2 · shares: Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 19:34 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 2,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000123 · wk-form4_1751571271.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,048 F1 · shares: Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:06 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000123 · wk-form4_1746475588.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,378 F1 · shares: Restricted shares, with restrictions lapsing on May 1, 2026, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 20:18 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 412 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000087 · wk-form4_1744229911.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,525 Underlying: Common Stock · 412 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · shares: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 473 units credited since October 7, 2024, as hypothetical reinvestment of dividend equivalents. Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 277 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000214 · wk-form4_1728504297.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,640 Underlying: Common Stock · 277 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F2 · price: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash. F3 · balance_after: Includes 232 units credited since April 5, 2024 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 17:16 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000129 · wk-form4_1720027008.xml · nonDerivative · entry 2 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,323 F2 · shares: Represents dividends accrued on shares underlying an award granted on July 3, 2023, that vested in full on July 1, 2024, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 17:16 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000129 · wk-form4_1720027008.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,313 F1 · shares: Shares represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2025. Read SEC document |
| May 02, 2024 Filed May 6, 2024 20:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000151 · wk-form4_1715025753.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,803 F1 · shares: Restricted shares, with restrictions lapsing on May 2, 2025, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award. Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 303 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000121 · wk-form4_1712693107.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,131 Underlying: Common Stock · 303 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 281 units credited since October 6, 2023, as hypothetical reinvestment of dividend equivalents. Read SEC document |
| October 06, 2023 Filed Oct 11, 2023 20:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 408 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000915389-23-000150 · wk-form4_1697054452.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,547 Underlying: Common Stock · 408 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 284 units credited since April 10, 2023 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:56 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-23-000151 · wk-form4_1688676981.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,563 F1 · shares: Shares represent an annual installment of non-employee director stock compensation pursuant to 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. Shares to vest on July 1, 2024. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:00 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,396 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-23-000103 · wf-form4_168357603713536.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,551 F1 · shares: Restricted shares, with restrictions lapsing on May 4, 2024, subject to certain conditions related to continued service as a director. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000915389-23-000070 · wf-form4_168132990103098.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,855 Underlying: Common Stock · 369 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 187 units credited since October 7, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 17:35 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000122 · form4.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,794 F4 · balance_after: Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2023. F3 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| October 07, 2022 Filed Oct 12, 2022 20:06 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-033481 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,299 Underlying: Common Stock · 417 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 359 units credited since May 5, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 21:27 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 731 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-22-000125 · wf-form4_165705640765428.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 F1 · shares: Shares represent an annual installment of non-employee director stock compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. Shares to vest on July 1, 2023. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:35 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 1,041 | $105.67 Strike: $0.00 | $110,002.47 |
DisclosureSEC source: 0000899243-22-017256 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,523 Underlying: Common Stock · 1,041 shares Expires not disclosed F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 4, 2023 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F3 · balance_after: Includes 15 units credited since April 1, 2022 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 270 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013704 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,467 Underlying: Common Stock · 270 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 113 units credited since October 1, 2021 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 14:34 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000506 · form4.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,414 F4 · balance_after: Includes 412 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2022. F3 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:31 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 294 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-039053 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,084 Underlying: Common Stock · 294 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 199 units credited since May 6, 2021 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantPhantom Stock · Derivative | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-21-000136 · wf-form4_162556635687301.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,003 Underlying: Common Stock · 775 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units convert 1 for 1 into common stock. F2 · shares: Shares represent deferred director compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. F3 · derivative.exercise_date: Exercisable in a single lump sum on February 15th of the calendar year after the year in which the reporting person is no longer a director. F4 · derivative.expiration_date: No expiration date. F5 · balance_after: Includes dividend equivalent rights earned based on total shares of Phantom Stock in Director's deferred stock account. Read SEC document |
| May 06, 2021 Filed May 10, 2021 16:58 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 807 | $124.04 Strike: $0.00 | $100,100.28 |
DisclosureSEC source: 0000899243-21-018840 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,591 Underlying: Common Stock · 807 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 5, 2022 annual meeting of stockholders, and are payable only in cash after termination of service as a director. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 18:44 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 270 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-015232 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,801 Underlying: Common Stock · 270 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · derivative.exercise_date: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · derivative.expiration_date: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 235 units credited since October 2, 2020 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 14:19 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 403 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000008 · edgar.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,002 F5 · balance_after: Includes 403 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2021. F4 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 14:29 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 384 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027540 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,296 Underlying: Common Stock · 384 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 6 units credited since May 7, 2020 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 21:18 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantPhantom Stock · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-20-000125 · wf-form4_159372470072618.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,999 Underlying: Common Stock · 1,725 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units convert 1 for 1 into common stock. F2 · shares: Shares represent deferred director compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. F3 · derivative.exercise_date: Exercisable in a single lump sum on February 15th of the calendar year after the year In which the reporting person is no longer a director. F4 · derivative.expiration_date: No expiration date. F5 · balance_after: Includes dividend equivalent rights earned based on total shares of Phantom Stock in Director's deferred stock account. Read SEC document |
| May 07, 2020 Filed May 11, 2020 17:37 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 1,654 | $60.47 Strike: $0.00 | $100,017.38 |
DisclosureSEC source: 0000899243-20-012545 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,906 Underlying: Common Stock · 1,654 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 6, 2021 annual meeting of stockholders, and are payable only in cash after termination of service as a director. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:21 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-010319 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,290 Underlying: Common Stock · 668 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 220 units credited since October 4, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 16:48 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-20-000002 · edgar.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 599 F5 · balance_after: Includes 453 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2020. F4 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 13:56 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 2,500 | $341.95 | $854,869.00 |
DisclosureSEC source: 0000049071-19-000111 · edgar.xml · nonDerivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 146 F5 · price: All shares sold at price of $341.9476. F4 · ownership.nature: Shares held by revocable trust account (March 2015), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Read SEC document |
| October 04, 2019 Filed Oct 8, 2019 13:55 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 424 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-025264 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,402 Underlying: Common Stock · 424 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 87 units credited since May 2, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:44 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantPhantom Stock · Derivative | 1,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-19-000065 · wf-form4_156219028177445.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,063 Underlying: Common Stock · 1,850 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units convert 1 for 1 into common stock. F2 · shares: Shares represent deferred director compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. F3 · derivative.exercise_date: Exercisable in a single lump sum on February 15th of the calendar year after the year In which the reporting person is no longer a director. F4 · derivative.expiration_date: No expiration date. F5 · balance_after: Includes dividend equivalent rights earned based on total shares of Phantom Stock in Director's deferred stock account. Read SEC document |
| May 02, 2019 Filed May 6, 2019 13:46 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 1,289 | $77.63 Strike: $0.00 | $100,065.07 |
DisclosureSEC source: 0000899243-19-012145 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,891 Underlying: Common Stock · 1,289 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 7, 2020 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F3 · balance_after: Includes 3 units credited since April 5, 2019 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| April 05, 2019 Filed Apr 9, 2019 16:47 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 366 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-010342 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,599 Underlying: Common Stock · 366 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 63 units credited since October 5, 2018 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 14:07 UTC | HUMANA INC HUM · Entity 1429 | GrantStock Unit · Derivative | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-19-000009 · edgar.xml · derivative · entry 4 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588 Underlying: Humana Common · 588 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2019. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2019. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2019. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2019. Read SEC document |
| October 05, 2018 Filed Oct 9, 2018 16:11 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 332 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026391 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,170 Underlying: Common Stock · 332 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 97 units credited since May 3, 2018 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:32 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantPhantom Stock · Derivative | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019460 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,038 Underlying: Common Stock · 1,400 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units convert 1 for 1 into common stock. F2 · shares: Shares represent deferred director compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. F3 · derivative.exercise_date: Exercisable in a single lump sum on February 15th of the calendar year after the year in which the reporting person is no longer a director. F4 · derivative.expiration_date: No expiration date. F5 · balance_after: Includes dividend equivalent rights earned based on total shares of Phantom Stock in Director's deferred stock account. Read SEC document |
| May 03, 2018 Filed May 7, 2018 15:52 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 827 | $102.87 Strike: $0.00 | $85,073.49 |
DisclosureSEC source: 0000899243-18-011593 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,741 Underlying: Common Stock · 827 shares Expires not disclosed F1 · derivative.exercise_price: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 2, 2019 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F2 · shares: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F2 · price: Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock into Phantom Stock Units. F1 · derivative.exercise_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 2, 2019 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 2, 2019 annual meeting of stockholders, and are payable only in cash after termination of service as a director. F1 · derivative.underlying_shares: Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest if the director is still serving as a director of the issuer immediately prior to election of directors at the May 2, 2019 annual meeting of stockholders, and are payable only in cash after termination of service as a director. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 16:46 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 293 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-009829 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,914 Underlying: Common Stock · 293 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 12 units credited since October 2, 2017 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:02 UTC | HUMANA INC HUM · Entity 1429 | GrantStock Unit · Derivative | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-18-000007 · edgar.xml · derivative · entry 4 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658 Underlying: Humana Common · 658 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2018. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2018. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2018. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2018. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 13:47 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantPhantom Stock Units · Derivative | 331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-023434 · doc4.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,609 Underlying: Common Stock · 331 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F2 · price: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F1 · derivative.exercise_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F1 · derivative.expiration_date: Phantom Stock units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director. F2 · derivative.underlying_shares: Automatic deferral of a portion of director's annual retainer fees that would otherwise have been paid in cash into the director's stock account of the Directors' Deferred Compensation Plan. F3 · balance_after: Includes 9 units credited since May 4, 2017 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:06 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantPhantom Stock · Derivative | 1,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001648210-17-000022 · primary_doc.xml · derivative · entry 1 OBRIEN JAMES J /KY · CIK 0001023582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,513 Underlying: Common Stock · 1,150 shares Expires not disclosed F1 · derivative.exercise_price: Phantom Stock units convert 1 for 1 into common stock. F2 · shares: Shares represent deferred director compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. F3 · derivative.exercise_date: Exercisable in a single lump sum on February 15th of the calendar year after the year in which the reporting person is no longer a director. F4 · derivative.expiration_date: No expiration date. F5 · balance_after: Includes dividend equivalent rights earned based on total shares of Phantom Stock in Director's deferred stock account. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.